DMAAR
Drugs Made In America Acquisition Corp Rights
DMAAR
DMAAR
24 hedge funds and large institutions have $2.22M invested in Drugs Made In America Acquisition Corp Rights in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$234K | |
| 2 | +$79.2K | |
| 3 | +$68.5K | |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$62.5K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$25.8K |
